The University of Medicine and Dentistry of New Jersey (UMDNJ) was under investigation by the U.S. Department of Justice (DOJ) for allegations of improper billing practices and violations of federal healthcare laws. In 2009, UMDNJ entered into a Corporate Integrity Agreement (CIA) with the government, which outlined steps the institution must take to ensure compliance with these laws.
The UMDNJ Corporate Integrity Agreement was a five-year agreement that required the institution to implement various compliance measures. These measures included the creation of a compliance program, the appointment of a Compliance Officer, and the establishment of a Compliance Committee. UMDNJ was also required to conduct annual training for all employees involved in billing and coding, as well as periodic audits to identify potential vulnerabilities.
The CIA also stipulated that UMDNJ must establish a hotline for reporting potential violations of federal healthcare laws and that the institution must disclose any overpayments received from federal healthcare programs. UMDNJ was also required to retain an Independent Review Organization (IRO) to review its compliance with the CIA and to report its findings to the government.
The CIA was a significant step forward for UMDNJ in terms of ensuring compliance with federal healthcare laws. However, it was not without its challenges. The institution was required to make significant changes to its infrastructure and to invest in compliance-related resources.
The UMDNJ CIA is an example of the government`s commitment to enforcing federal healthcare laws and holding institutions accountable for improper billing practices. It is also a reminder of the importance of compliance programs in healthcare organizations and the steps that must be taken to ensure they are effective.
In conclusion, the UMDNJ Corporate Integrity Agreement was a comprehensive and detailed roadmap for ensuring compliance with federal healthcare laws. While it required significant investment and changes, it was ultimately a positive step forward for UMDNJ and a reminder of the importance of compliance in the healthcare industry.